SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-20-072904
Filing Date
2020-03-13
Accepted
2020-03-13 16:17:27
Documents
6
Effectiveness Date
2020-03-13

Document Format Files

Seq Description Document Type Size
1 S-8 d887912ds8.htm S-8 39739
2 EX-5.1 d887912dex51.htm EX-5.1 8227
3 EX-23.2 d887912dex232.htm EX-23.2 1691
4 GRAPHIC g887912g38x78.jpg GRAPHIC 14545
5 GRAPHIC g887912g67x04.jpg GRAPHIC 3578
6 GRAPHIC g887912g75j56.jpg GRAPHIC 6961
  Complete submission text file 0001193125-20-072904.txt   85658
Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459
Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600
Karyopharm Therapeutics Inc. (Filer) CIK: 0001503802 (see all company filings)

IRS No.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-237160 | Film No.: 20712928
SIC: 2834 Pharmaceutical Preparations